MedTrace Logo

Cost-effectiveness of Extracorporeal Life Support Treatment

NCT02837419 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2019-09-25

No results posted yet for this study

Summary

This study evaluates patients on ECLS treatment as considered appropriate with mortality and health related Quality of life and costs.

Conditions

  • Critically Ill

Interventions

BEHAVIORAL

Health related Quality of life EQ-5D

Quality of Care

Sponsors & Collaborators

  • University Medical Center Groningen

    lead OTHER

Principal Investigators

  • walter m van den Bergh, MD, PhD · department of critical care, UMCG

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-01
Primary Completion
2020-01-01
Completion
2020-01-01

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02837419 on ClinicalTrials.gov